NxStage Medical, Inc. (NXTM) Reports Record Revenue for the Third Quarter of Fiscal 2012
11/9/2012 9:25:44 AM
LAWRENCE, Mass., Nov. 8, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record financial results for the third quarter ended September 30, 2012, with total revenue above the top end of its guidance range.
Revenue for the third quarter of 2012 increased 9% to $61.2 million, compared with revenue of $55.9 million for the third quarter of 2011. The higher revenues were driven by increased adoption of the NxStage System One™.
comments powered by